{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:26Z","timestamp":1791316706987,"version":"4.3.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Outstanding Youth Foundation of Heilongjiang Province of China"},{"name":"Postgraduate Research & Practice Innovation Program of Harbin Medical University"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62473119"],"award-info":[{"award-number":["62473119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370716"],"award-info":[{"award-number":["32370716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heilongjiang Postdoctoral Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.1038\/s41416-026-03390-5","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:47:11Z","timestamp":1775216831000},"page":"1633-1645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular phenotypes stratify small cell lung cancer for targeted therapy and immunotherapy"],"prefix":"10.1038","volume":"134","author":[{"given":"Juxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6868-2752","authenticated-orcid":false,"given":"Shilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-6544","authenticated-orcid":false,"given":"Lishuang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"3390_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJMra0802714","volume":"359","author":"RS Herbst","year":"2008","unstructured":"Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367\u201380.","journal-title":"N Engl J Med"},{"key":"3390_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121:664\u201372.","journal-title":"Cancer"},{"key":"3390_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100408","volume":"7","author":"L Paz-Ares","year":"2022","unstructured":"Paz-Ares L, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, et al. Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN. ESMO Open. 2022;7:100408.","journal-title":"ESMO Open"},{"key":"3390_CR4","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1200\/JCO.20.00793","volume":"38","author":"CM Rudin","year":"2020","unstructured":"Rudin CM, Awad MM, Navarro A, Gottfried M, Peters S, Csoszi T, et al. Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study. J Clin Oncol. 2020;38:2369\u201379.","journal-title":"J Clin Oncol"},{"key":"3390_CR5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","volume":"394","author":"L Paz-Ares","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019;394:1929\u201339.","journal-title":"Lancet"},{"key":"3390_CR6","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn L, Mansfield AS, Szczesna A, Havel L, Krzakowski M, Hochmair MJ, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379:2220\u20139.","journal-title":"N Engl J Med"},{"key":"3390_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39:346\u201360.e7.","journal-title":"Cancer Cell"},{"key":"3390_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19:289\u201397.","journal-title":"Nat Rev Cancer"},{"key":"3390_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature22323","volume":"545","author":"JS Lim","year":"2017","unstructured":"Lim JS, Ibaseta A, Fischer MM, Cancilla B, O\u2019Young G, Cristea S, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017;545:360\u20134.","journal-title":"Nature"},{"key":"3390_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","volume":"38","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Micinski AM, Kastner DW, Guo B, Wait SJ, Spainhower KB, et al. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell. 2020;38:60\u201378.e12.","journal-title":"Cancer Cell"},{"key":"3390_CR11","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"MK Baine","year":"2020","unstructured":"Baine MK, Hsieh MS, Lai WV, Egger JV, Jungbluth AA, Daneshbod Y, et al. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol. 2020;15:1823\u201335.","journal-title":"J Thorac Oncol"},{"key":"3390_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41392-022-01150-4","volume":"7","author":"Y Tian","year":"2022","unstructured":"Tian Y, Li Q, Yang Z, Zhang S, Xu J, Wang Z, et al. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer. Signal Transduct Target Ther. 2022;7:346.","journal-title":"Signal Transduct Target Ther"},{"key":"3390_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","volume":"187","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang J, Guo C, Wang M, Wang C, Yan Y, et al. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies. Cell. 2024;187:184\u2013203.e28.","journal-title":"Cell"},{"key":"3390_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","volume":"42","author":"BY Nabet","year":"2024","unstructured":"Nabet BY, Hamidi H, Lee MC, Banchereau R, Morris S, Adler L, et al. Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell. 2024;42:429\u201343.e4.","journal-title":"Cancer Cell"},{"key":"3390_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan JM, Quintanal-Villalonga A, Gao VR, Xie Y, Allaj V, Chaudhary O, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39:1479\u201396.e18.","journal-title":"Cancer Cell"},{"key":"3390_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401.","journal-title":"Science"},{"key":"3390_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105062","volume":"102","author":"S Park","year":"2024","unstructured":"Park S, Hong TH, Hwang S, Heeke S, Gay CM, Kim J, et al. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer. EBioMedicine. 2024;102:105062.","journal-title":"EBioMedicine"},{"key":"3390_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47\u201353.","journal-title":"Nature"},{"key":"3390_CR19","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u2013i90.","journal-title":"Bioinformatics"},{"key":"3390_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"3390_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"3390_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"L Kumar","year":"2007","unstructured":"Kumar L. M EF. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007;2:5\u20137.","journal-title":"Bioinformation"},{"key":"3390_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"3390_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/tlcr.2018.02.02","volume":"7","author":"W Zhang","year":"2018","unstructured":"Zhang W, Girard L, Zhang YA, Haruki T, Papari-Zareei M, Stastny V, et al. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes. Transl Lung Cancer Res. 2018;7:32\u201349.","journal-title":"Transl Lung Cancer Res"},{"key":"3390_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6:99\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"3390_CR26","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.1818210116","volume":"116","author":"A Miranda","year":"2019","unstructured":"Miranda A, Hamilton PT, Zhang AW, Pattnaik S, Becht E, Mezheyeuski A, et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc Natl Acad Sci USA. 2019;116:9020\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3390_CR27","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","volume":"19","author":"A Eustace","year":"2013","unstructured":"Eustace A, Mani N, Span PN, Irlam JJ, Taylor J, Betts GN, et al. A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. Clin Cancer Res. 2013;19:4879\u201388.","journal-title":"Clin Cancer Res"},{"key":"3390_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"3390_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01460-0","volume":"8","author":"M Lauss","year":"2017","unstructured":"Lauss M, Donia M, Harbst K, Andersen R, Mitra S, Rosengren F, et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat Commun. 2017;8:1738.","journal-title":"Nat Commun"},{"key":"3390_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48\u201361.","journal-title":"Cell"},{"key":"3390_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248\u201362.","journal-title":"Cell Rep"},{"key":"3390_CR32","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00109-022-02266-4","volume":"100","author":"S Zhang","year":"2022","unstructured":"Zhang S, Li M, Tan Y, Zhang J, Liu Y, Jiang W, et al. Identification of mutational signature for lung adenocarcinoma prognosis and immunotherapy prediction. J Mol Med. 2022;100:1755\u201369.","journal-title":"J Mol Med"},{"key":"3390_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov A, Sill M, Luck S, Rucker F, Dohner K, Bullinger L, et al. SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med Genomics. 2010;3:21.","journal-title":"BMC Med Genomics"},{"key":"3390_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, et al. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun. 2023;14:5123.","journal-title":"Nat Commun"},{"key":"3390_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ggn2.202100060","volume":"3","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang H, Zhang L, Li D, Qi M, Zhang L, et al. Single-cell transcriptome identifies drug-resistance signature and immunosuppressive microenvironment in metastatic small cell lung cancer. Adv Genet. 2022;3:2100060.","journal-title":"Adv Genet"},{"key":"3390_CR36","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51:D870\u2013D6.","journal-title":"Nucleic Acids Res"},{"key":"3390_CR37","doi-asserted-by":"publisher","first-page":"ii141","DOI":"10.1093\/bioinformatics\/btac499","volume":"38","author":"A Dietrich","year":"2022","unstructured":"Dietrich A, Sturm G, Merotto L, Marini F, Finotello F, List M. SimBu: bias-aware simulation of bulk RNA-seq data with variable cell-type composition. Bioinformatics. 2022;38:ii141\u2013ii7.","journal-title":"Bioinformatics"},{"key":"3390_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"3390_CR39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","volume":"328","author":"JM Bland","year":"2004","unstructured":"Bland JM, Altman DG. The logrank test. BMJ. 2004;328:1073.","journal-title":"BMJ"},{"key":"3390_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/path.6033","volume":"259","author":"J Zhang","year":"2023","unstructured":"Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, et al. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. J Pathol. 2023;259:205\u201319.","journal-title":"J Pathol"},{"key":"3390_CR41","doi-asserted-by":"crossref","unstructured":"Betriu N, Bertran-Mas J, Andreeva A, Semino CE. Syndecans and pancreatic ductal adenocarcinoma. Biomolecules. 2021;11:349.","DOI":"10.3390\/biom11030349"},{"key":"3390_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.4258","volume":"232","author":"TS Lau","year":"2014","unstructured":"Lau TS, Chung TK, Cheung TH, Chan LK, Cheung LW, Yim SF, et al. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. J Pathol. 2014;232:43\u201356.","journal-title":"J Pathol"},{"key":"3390_CR43","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","volume":"68","author":"F Hu","year":"2010","unstructured":"Hu F, Padukkavidana T, Vaegter CB, Brady OA, Zheng Y, Mackenzie IR, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron. 2010;68:654\u201367.","journal-title":"Neuron"},{"key":"3390_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13024-016-0132-1","volume":"11","author":"C Altmann","year":"2016","unstructured":"Altmann C, Vasic V, Hardt S, Heidler J, Haussler A, Wittig I, et al. Progranulin promotes peripheral nerve regeneration and reinnervation: role of notch signaling. Mol Neurodegener. 2016;11:69.","journal-title":"Mol Neurodegener"},{"key":"3390_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/1538-7445.AM2025-5","volume":"85","author":"GJ Jordan","year":"2025","unstructured":"Jordan GJ, Gallo C, Robinson M, Lujano-Olazaba O, House CD. Abstract 5: Noncanonical NF-kB and notch signaling activity supports ovarian cancer stem-like cells following chemotherapy. Cancer Res. 2025;85:5.","journal-title":"Cancer Res"},{"key":"3390_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. 2021;12:832.","journal-title":"Nat Commun"},{"key":"3390_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406653","volume":"11","author":"X Liu","year":"2024","unstructured":"Liu X, Wang C, Huang Y, Lv Q, Yu C, Ying J, et al. Abnormal cellular populations shape thymic epithelial tumor heterogeneity and anti-tumor by blocking metabolic interactions in organoids. Adv Sci. 2024;11:e2406653.","journal-title":"Adv Sci"},{"key":"3390_CR48","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.25777","volume":"56","author":"H Li","year":"2012","unstructured":"Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, et al. Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2012;56:1342\u201351.","journal-title":"Hepatology"},{"key":"3390_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","volume":"21","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Jiang H, Yang N, Shen S, Huang D, Jia L, et al. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cell Mol Immunol. 2024;21:47\u201359.","journal-title":"Cell Mol Immunol"},{"key":"3390_CR50","doi-asserted-by":"publisher","first-page":"12723","DOI":"10.1093\/nar\/gkac1063","volume":"50","author":"F Li","year":"2022","unstructured":"Li F, Negi V, Yang P, Lee J, Ma K, Moulik M, et al. TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism. Nucleic Acids Res. 2022;50:12723\u201338.","journal-title":"Nucleic Acids Res"},{"key":"3390_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.trecan.2019.04.001","volume":"5","author":"PC Calses","year":"2019","unstructured":"Calses PC, Crawford JJ, Lill JR, Dey A. Hippo pathway in cancer: aberrant regulation and therapeutic opportunities. Trends Cancer. 2019;5:297\u2013307.","journal-title":"Trends Cancer"},{"key":"3390_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tibs.2022.12.005","volume":"48","author":"AV Pobbati","year":"2023","unstructured":"Pobbati AV, Kumar R, Rubin BP, Hong W. Therapeutic targeting of TEAD transcription factors in cancer. Trends Biochem Sci. 2023;48:450\u201362.","journal-title":"Trends Biochem Sci"},{"key":"3390_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","volume":"19","author":"A Dey","year":"2020","unstructured":"Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480\u201394.","journal-title":"Nat Rev Drug Discov"},{"key":"3390_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114248","volume":"159","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yang Y, Li X, Yuan X, Chu Q. Targeting the Notch signaling pathway and the Notch ligand, DLL3, in small cell lung cancer. Biomed Pharmacother. 2023;159:114248.","journal-title":"Biomed Pharmacother"},{"key":"3390_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbrc.2019.04.130","volume":"514","author":"J Huang","year":"2019","unstructured":"Huang J, Cao D, Sha J, Zhu X, Han S. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer. Biochem Biophys Res Commun. 2019;514:853\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"3390_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.713031","volume":"14","author":"J Terryn","year":"2021","unstructured":"Terryn J, Verfaillie CM, Van Damme P. Tweaking progranulin expression: therapeutic avenues and opportunities. Front Mol Neurosci. 2021;14:713031.","journal-title":"Front Mol Neurosci"},{"key":"3390_CR57","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1182\/blood-2003-04-1034","volume":"102","author":"P Cheng","year":"2003","unstructured":"Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood. 2003;102:3980\u20138.","journal-title":"Blood"},{"key":"3390_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02410-z","volume":"18","author":"Z Lu","year":"2020","unstructured":"Lu Z, Meng S, Chang W, Fan S, Xie J, Guo F, et al. Mesenchymal stem cells activate Notch signaling to induce regulatory dendritic cells in LPS-induced acute lung injury. J Transl Med. 2020;18:241.","journal-title":"J Transl Med"},{"key":"3390_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-023-01464-y","volume":"16","author":"CM Rudin","year":"2023","unstructured":"Rudin CM, Reck M, Johnson ML, Blackhall F, Hann CL, Yang JC, et al. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. J Hematol Oncol. 2023;16:66.","journal-title":"J Hematol Oncol"},{"key":"3390_CR60","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jtho.2023.07.012","volume":"18","author":"SM Pearsall","year":"2023","unstructured":"Pearsall SM, Williamson SC, Humphrey S, Hughes E, Morgan D, Garcia Marques FJ, et al. Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry. J Thorac Oncol. 2023;18:1362\u201385.","journal-title":"J Thorac Oncol"},{"key":"3390_CR61","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"V Wittamer","year":"2003","unstructured":"Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198:977\u201385.","journal-title":"J Exp Med"},{"key":"3390_CR62","first-page":"1","volume":"3","author":"BA Zabel","year":"2014","unstructured":"Zabel BA, Kwitniewski M, Banas M, Zabieglo K, Murzyn K, Cichy J. Chemerin regulation and role in host defense. Am J Clin Exp Immunol. 2014;3:1\u201319.","journal-title":"Am J Clin Exp Immunol"},{"key":"3390_CR63","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, et al. Natural coevolution of tumor and immunoenvironment in glioblastoma. Cancer Discov. 2022;12:2820\u201337.","journal-title":"Cancer Discov"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03390-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:02:10Z","timestamp":1779091330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03390-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,5]]}},"alternative-id":["3390"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03390-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All human samples used in this study were approved by the Ethics Committee of Harbin Medical University Cancer Hospital (ethics number: YD2025-14), and informed consent was obtained from all participants. All experiments were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}